Fig. 1.

miR-3614-5p is decreased in CRC plasma exosomes, tissues, and cell lines. (A) The flowchart of identifying differentially expressed miRNAs in plasma exosomes between the healthy control and CRC patients. (B and C) The volcano plots a heatmap showing the differentially expressed exosomal miRNAs between CRC patients and healthy controls. (D) The differentially expressed miRNAs in CRC tissues from TCGA databases. (E) Venn diagram showed the overlapping miRNAs among miRNA-seq of exosomes, differentially expressed miRNAs in CRC tissues from the TCGA database, and prognostic factor from the TCGA database. (F) RT-qPCR was performed to detect the expression of miR-3614-5p in the plasm or plasm exosomes of CRC patients and healthy controls. (G and H) RT-qPCR was performed to detect the expression of miR-3614-5p in CRC tissues or CRC cell lines and adjacent tissues or normal cell line. (I) The TCGA database shows the expression profile of miR-3614-5p in colorectal adenocarcinoma (COAD). (J) The Kaplan-Meier survival curve showed a correlation between miR-3614-5p expression and overall survival in CRC patients